Samenvatting
The development of a macromolecular conjugate of a multitargeted tyrosine kinase inhibitor is described that can be used for renal-specific delivery into proximal tubular cells. A novel sunitinib analogue, that is, 17864, is conjugated to a NH 2-PAMAM-G3 dendrimer via the platinum (II)-based Universal Linkage System (ULS™). The activity of 17864 is retained after coordination to the ULS linker alone or when coupled to NH 2-PAMAM-G3. 17864-UlS-NH 2-PAMAM-G3 is non-toxic to proximal tubular cells in vitro. After intravenous administration to mice, 17864-UlS-NH 2-PAMAM-G3 rapidly and efficiently accumulates in the kidneys. These results are encouraging for future studies focusing on the development of novel therapeutics for the treatment of renal diseases.
| Originele taal-2 | Engels |
|---|---|
| Pagina's (van-tot) | 93-103 |
| Aantal pagina's | 11 |
| Tijdschrift | Macromolecular Bioscience |
| Volume | 12 |
| Nummer van het tijdschrift | 1 |
| DOI's | |
| Status | Gepubliceerd - jan. 2012 |
| Extern gepubliceerd | Ja |